ArticleThe oncologist2023

Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.

Fanny Le Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.